FDA Let Pharma Co. 'Sidestep' Application Rules, Court Told
The Food and Drug Administration has been hit with a suit alleging it wrongly allowed a drugmaker to expand the scope of its application to market a generic version of a...To view the full article, register now.
Already a subscriber? Click here to view full article